Abstract Exposure to cigarette smoke represents the most important risk factor for the development of chronic obstructive pulmonary disease (COPD). COPD is characterized by chronic inflammation of the airways, imbalance of proteolytic activity resulting in the destruction of lung parenchyma, alveolar hypoxia, oxidative stress, and apoptosis. Sphingolipids are structural membrane components whose metabolism is altered during stress. Known as apoptosis and inflammation inducer, the sphingolipid ceramide was found to accumulate in COPD airways and its plasma concentration increased as well. The present study investigates the role of sphingolipids in the cigarette smoke-induced damage of human airway epithelial cells. Lung epithelial cells were pre-treated with sphingolipid synthesis inhibitors (myriocin or XM462) and then exposed to a mixture of nicotine, acrolein, formaldehyde, and acetaldehyde, the major toxic cigarette smoke components. The inflammatory and proteolytic responses were investigated by analysis of the mRNA expression (RT-PCR) of cytokines IL-1β and IL-8, and matrix metalloproteinase-9 and of the protein expression (ELISA) of IL-8. Ceramide intracellular amounts were measured by LC-MS technique. Ferricreducing antioxidant power test and superoxide anion radical scavenging activity assay were used to assess the antioxidant power of the inhibitors of ceramide synthesis. We here show that ceramide synthesis is enhanced under treatment with a cigarette smoke mixture correlating with increased expression of inflammatory cytokines and matrix metalloproteinase 9. The use of inhibitors of ceramide synthesis protected from smoke induced damages such as inflammation, oxidative stress, and proteolytic imbalance in airways epithelia.
Introduction
Smoking is the major environmental risk factor for the development and progression of chronic obstructive pulmonary disease (COPD) (Eisner et al. 2010) , the third leading cause of mortality worldwide as reported (Lozano et al. 2012 ). Long-term inhalation of noxious air pollutants including cigarette smoke (CS) stimulates an inflammatory signaling cascade in the airways resulting into a strong production of cytokines and chemokines that induce a chronic inflammation condition. Prolonged exposures weaken the lung defenses and compromise the immune system and the host ability to arrange a proper immune response via the induction of injury mechanisms such as oxidative stress, apoptosis, and inflammation (Stampfli and Anderson 2009) . Following repeated inhalations, cigarette smoke substances became toxic and trigger the generation of reactive oxygen species (ROS) (Azad et al. 2008 ). Thus, cell antioxidant defenses are unable to keep ROS level below a harmful threshold and the deleterious process caused by oxidative stress and inflammation overwhelms the lung protective mechanisms. This situation results in the subsequent parenchyma damage and destruction, via uncontrolled proteolysis by proteinases such as metalloproteinases (MMP) . In fact, alterations in MMP expression seem to be a sensitive biomarker of lung injury following CS exposure (Moon et al. 2014) . It has been reported that inflammatory tissue damage in COPD continues beyond smoking cessation (Gamble et al. 2007) .
CS is a toxic mixture of about 5000 chemical compounds, including not only inflammatory agents but also carcinogens, toxicants, irritants, and tumor promoters (Eldridge et al. 2015) . The role of every single component on the smoke induced damage has not been fully understood. Among the most hazardous CS components, nicotine is the most abundant alkaloid and main responsible for the addiction to tobacco (Caron et al. 2005) , while the class of short-chain aldehydes such as acrolein, formaldehyde, and acetaldehyde are quite abundant (Counts et al. 2005) . All mentioned compounds are involved in the loss of lung endothelial barrier function and induced apoptosis of lung epithelial cells associated to ROS production and inflammation (Schweitzer et al. 2015) . Aldehydes contained in CS play a critical role in inflammatory cytokine production in macrophages and human bronchial epithelial cells (van der Toorn et al. 2013) . Further, it has been shown that these aldehydes can delay the resolution of inflammation exacerbating the acute airway inflammatory response mediated by neutrophils (Finkelstein et al. 2005) . In particular, acrolein, a highly reactive aldehyde produced endogenously at inflammation sites, is involved in increased mucin production and regulation of lung matrix metalloproteinase 9 (MMP-9), which may result in decreased lung function in COPD patients (Deshmukh et al. 2008) .
Sphingolipids (SPL) are structural membrane components and signaling mediators involved in inflammation and apoptosis (Adada et al. 2016) . Ceramide (Cer), the structural core of the sphingolipids, is de novo biosynthesized from fatty acid addition to a sphingosine backbone and is used as precursor of sphingomyelin and complex glycosphingolipids or hydrolyzed back to sphingosine and free fatty acid (Adada et al. 2016) .
Due to the crucial role of Cer in multiple cellular processes, the dysregulation of Cer homeostasis may lead to dramatic cellular events; hence, its intracellular level should be kept in a confined range. Pulmonary inflammatory diseases like cystic fibrosis (CF) and COPD have been associated with enhanced airway Cer levels in several human studies (Brodlie et al. 2010; Lea et al. 2016) In fact, Cer is a wellknown apoptosis inducer and an activator of inflammatory transcriptional factors. Previous studies have highlighted SPL modulation and Cer accumulation in smokers either affected or not by COPD (Telenga et al. 2014) and in the lung of CS exposed animals (Petrache et al. 2005) . Augmented Cer levels were found to be associated with lung endothelial and epithelial cell apoptosis in CS exposed murine models (Bodas et al. 2011; Filosto et al. 2011) . Recently, in COPD patients and CS-exposed mice, some authors have reported Cer accumulation derived by augmented sphingomyelin hydrolysis that correlates with increased activity of neutral or acid sphingomyelinases (Filosto et al. 2011; Lea et al. 2016) .
We previously demonstrated that the pharmacological reduction of Cer by myriocin (Myr), an inhibitor of the first reaction of de novo SPL synthesis, significantly reduces Cer stress-induced accumulation and ameliorates the damages induced by inflammation in animal models of CF and myocardial ischemia/reperfusion (Caretti et al. 2014; Caretti et al. 2016; Reforgiato et al. 2016) . Moreover, we demonstrated that XM462, an inhibitor of the reaction that originates Cer from its precursor dihydroceramide, ameliorates stress response and promotes cell survival (Gagliostro et al. 2012) . The hypothesis of the present study is that exposure of epithelial cells to a mixture of nicotine, acrolein, formaldehyde, and acetaldehyde, known components of CS, provokes an inflammatory stress state that modifies cellular metabolism causing an increase in the de novo biosynthesis of SPL and resulting in Cer accumulation. We then investigate the therapeutic potential of two SPL inhibitors, namely Myr and XM462, in reducing CS induced inflammation, proteolytic imbalance, and oxidative stress in human airway epithelia.
Methods

Materials
The following chemicals nicotine, acrolein, formaldehyde, and acetaldehyde were purchased from Sigma-Aldrich (Italy); LHC-8 without gentamicin culture media from Gibco (US); FBS from EuroClone Life Science Division (Italy); SYBR Green system from Qiagen (Italy); synthetic oligonucleotides from Eurofins Genomics (Italy); and myriocin from Fermentek LTD (Israel). XM462 was synthesized as previously reported (Munoz-Olaya et al. 2008 ).
Preparation of stock solutions
Myriocin powder was dissolved in dimethyl sulfoxide (DMSO) by warming up to 37°C to obtain the stock solution concentration of 2 mM. XM462 was dissolved in ethanol to obtain the stock solution of 10 mM. Aqueous stock solutions of 100 mM nicotine, 10 mM acrolein, 10 mM formaldehyde, and 100 mM acetaldehyde were prepared and used within the week.
Cultures conditions and treatments
C38 human bronchial epithelial cells (LGC Promochem, USA) were kindly provided by the Cystic Fibrosis Animal Core Facility (San Raffaele Hospital, Milan, Italy) and were grown as previously described (Caretti et al. 2014) . Onehundred-millimeter plates were seeded with 1 × 10 6 cells/ plate. Twenty-four hours later, medium was replaced with 10 mL of fresh one, containing either Myr (10 μM), XM462 (20 μM), or the medium alone. After 6 h, a mixture (MIX) containing nicotine (1 mM), acrolein (35 μM), formaldehyde (80 μM), and acetaldehyde (1 mM) was added and incubation proceeded for further 8 h. Concentrations of CS components used were in accordance with Cheah et al. (2013) with minor modifications.
Liquid chromatography tandem mass spectrometry (LC-MS) analysis
Sphingolipids from C38 cells were fortified with internal standard N-lauroyl-D-erythro-sphingosine (0.2 nmol) and extracted as previously described (Merrill et al. 2005 ) with some modifications. The liquid chromatography tandem mass spectrometry system consisted of a Dionex Ultimate 3000 system connected to a AB Sciex 3200 Q Trap LC/MS/MS instrument (AB Sciex, Milan, IT), operated in the positive electrospray ionization (ESI) mode, according to the manufacturer's specifications. Separation was accomplished in a ACQUITY UPLC BEH C8 Column, 130 Å, 1.7 μm, 2.1 mm × 100 mm (Waters, Millford, MA). The two mobile phases were as follows: phase A, 2 mM ammonium formate in water and phase B, 1 mM ammonium formate in methanol, both contained 0.2% formic acid (v/v). A linear gradient was programmed-0.0 min, 20% A; 3 min, 10% A; 6 min, 10% A; 15 min, 1% A; 18 min, 1% A; 20 min, 20% A; 22 min, 20% A. The flow rate was 0.3 mL/min. The column was held at 30°C. The linear dynamic range was determined by injecting standard mixtures. Identification and quantification of all targeted ceramides was accomplished by multiple reactions monitoring (MRM) by following the transition from the [MH + ] species to the common ion fragment 264.4 m/z. Total ceramide content was expressed as picomoles normalized by total protein content (mg).
RNA extraction and quantitative RT-PCR
Total RNAwas extracted and reverse transcribed according to the manufacturer's instructions (Promega). The conditions for quantitative RT-PCR and human gene primer sequences for IL-1β, IL-8, and GAPDH were previously reported (Dechecchi et al. 2011) . The primer sequences for MMP-9 were designed: forward TGCGTCTTCCCCTTCACTTT and reverse TCGCTGGT ACAGGTCGAGTA. Results were calculated by 2 −ΔΔCt method (Arocho et al. 2006) vs untreated control cells. RT-PCR determinations were performed in triplicate.
ELISA IL-8 was determined in C38 culture media by biomarker multiplex immunoassays on Luminex® Platform. Data were normalized on cell protein concentration (Bradford assay).
Determinations have been performed in duplicate.
Ferric reducing antioxidant power test
The ferric reducing antioxidant power (FRAP) assay was performed according to the previously published method (Benzie and Strain 1999) with minor modifications. As reported by Signorelli et al. (2015) , the FRAP solution was prepared with 100 mL of acetate buffer 300 mM, adjusted to pH 3.6 with acetic acid, and were mixed with 10 mL of ferric chloride hexahydrate 20 mM (in distilled water) and 10 mL of 2,4,6-tris (2-pyridyl)-striazine 10 mM (in HCl 40 mM). One hundred milliliters of sample were added to 3 mL of a freshly prepared FRAP solution in glass test tubes in triplicate and the absorbance measured at 593 nm after 5 min of incubation at 37°C against a blank of acetate buffer. Aqueous solutions of FeSO4.7H2O (100-1000 mM) were used for the calibration. FRAP value (μM Fe (II) normalized by μg of protein) of the samples were expressed as fold change vs control (Zarban et al. 2009 ).
Superoxide anion radical scavenging activity assay
The assay was carried out at room temperature according to Yen and Duh (1994) with modifications. In a plastic tube, 1.195 mL of phosphate buffer 50 mM (pH = 7.4), 5 μL of sample at different concentrations, 100 μL of 2.34 mM NADH, and 100 μL of 300 μM phenazine methosulfate were mixed. Then 100 μL of 750 μM nitro blue tetrazolium (NBT) were added to start the reaction. The reduction of NBT was monitored with a kinetic of 2 min. Caffeic acid was used as reference compound. At the end, the absorbance was measured using a UV/VIS spectrophotometer Cary 50 Bio (Varian, Palo Alto, CA, USA). The percentage of inhibition was calculated using the following formula: Inhibition (%) = [(A0 -As)/A0] where A0 is the absorbance of the control and As is the absorbance of the sample or of the standard compound. All the measurements were performed in triplicate. The percentage of inhibition of the superoxide anion vs tested compound concentrations normalized by micrograms of protein was expressed as fold change vs control.
Statistical analysis
Data significance was evaluated by one-way ANOVA followed by the Bonferroni post-test when significant (P < 0.05). Linear correlation analysis was performed by the parametric Pearson method (significant when P < 0.05). Data, expressed as mean ± SD, are obtained from three individual experiments, performed with either duplicate or triplicate samples for each treatment (with the exception of single samples for LC-MS measurement). Analysis was performed by GraphPad Instat software (La Jolla, CA, USA) and graph illustrations by GraphPad Prism software (La Jolla, CA, USA).
Results
As an in vitro model, to study the effects of CS components on lung epithelial cells, the C38 cell line was used. To investigate the possible role of Cer in CS-induced damage, we pre-treated C38 with two inhibitors of the SPL synthesis, Myr and XM462. An approximately twofold increase in Cer was measured in CS exposed cells (MIX) relative to the basal levels (874.9 ± 288 pmol/mg protein in untreated cells vs 1782.4 ± 219.4 pmol/mg protein in the CS treated cells), within 8 h (Fig. 1a) . The use of the Cer synthesis inhibitors significantly reduced total Cer levels in CS-exposed cells moving from 1782.4 ± 219.4 pmol/mg protein in the CS-treated cells to 1301.1 ± 152.5 and 1218.4 ± 243.8 pmol/mg protein in the Myr and XM462 pre-treated cells, respectively.
To characterize the inflammatory stress response of the CS exposed cells, we quantified the messenger RNA (mRNA) of IL-1β and IL-8 after 8 h of CS treatment. CS mixture augmented IL-1β and IL-8 transcription up to tenfold and eightfold respectively compared to untreated cells (Fig. 1b) . When we inhibited the Cer synthesis, the transcription of the proinflammatory cytokines was reduced significantly as reported in Fig. 1b. For IL-1β , the mRNA level decreased about 1.5-fold following Myr treatment and fivefold (P < 0.01) when we used XM462. In the case of IL-8 mRNA, we found that the expression halved with both the inhibitors and this reduction was statistically significant (P < 0.05). Moreover, we found that IL-8 mRNA expression directly correlates with the total Cer content (P < 0.001) (Fig. 1c) .
The expression of the pro-inflammatory cytokine IL-8 released in the media of C38 was quantified by ELISA (Fig. 1d) . In accordance with the transcriptional activity, the secreted IL-8 augmented in CS-stressed cells with respect to the control untreated cells. The inhibition of de novo Cer synthesis in C38 stressed cells was associated to a reduction of IL-8 expression, Significance was evaluated by one-way ANOVA, followed by Bonferroni post-test. For IL-1β mRNA; P = 0.0002; ***P < 0.001 Ctrl vs MIX; # P < 0.05 Myr/MIX vs MIX; ## P < 0.01 XM462/MIX vs MIX. For IL-8 mRNA; P < 0.0001; ***P < 0.001 Ctrl vs MIX; ## P < 0.01 Myr/MIX, XM462/MIX vs MIX. c IL-8 mRNA level expression directly correlates with the corresponding total Cer content (picomoles/mg protein). Significance was evaluated by Linear correlation, P = 0.0002, r 2 = 0.60, n = 18. d IL-8 cytokine content, expressed as picograms per milliliter, was measured by ELISA in culture media of C38 cells. Significance was evaluated by one-way ANOVA, followed by Bonferroni post-test. P = 0.0007; **P < 0.01 Ctrl vs MIX; # P < 0.05 Myr/MIX vs MIX. Data, expressed as mean ± SD, are obtained from three individual experiments with either single (LC-MS), duplicate (ELISA), or triplicate (RT-PCR) samples for each treatment statistically significant (P < 0.05) when Myr pre-treatment was performed (Fig. 1d) .
Oxidative damage generated by free radicals plays an important role in CS-related pathologies. We therefore investigated if SPL inhibitors could stimulate a defensive response to oxidative stress. To do so, we measured the production of antioxidant factors stimulated by SPL inhibitors and we used both the FRAP test and the superoxide anion scavenging activity test. By means of the FRAP assay, quantifying the total concentration of reduced Fe (II) in the cell culture media of each treatment group, we observed a 20% reduction of the antioxidant power in CS treated vs control cells, although the reduction was not statistically significant (Fig. 2a, left  panel) . When cells were pre-treated with both inhibitors, we found that the antioxidant activity raised significantly, with Myr almost doubling the activity, with respect to the CSstressed cells (P < 0.05) (Fig. 2a, left panel) . Whereas the antioxidant response measured by superoxide radical scavenging activity was not significantly altered in CS-treated cells, the pre-treatment with Myr or XM462 significantly increased it vs the stressed cells (P < 0.001) (Fig. 2a, right  panel) . This observation indicates that blocking the synthesis of SPL not only reduces cell stress and demise but also stimulates survival and protective mechanisms, such as antioxidant factors production and release.
Exposure to CS triggers the imbalance of matrix metalloproteinases that promotes tissue damage. We studied the MMP-9 expression by RT-PCR in order to find possible fluctuations of its transcription in our CS-damaged epithelial cell model. RT-PCR analysis showed that MMP-9 was significantly overexpressed under CS mixture treatment and this overexpression was significantly rescued when cells were pre-treated with Myr (P < 0.05) or XM462 (P < 0.01) (Fig. 2b ).
Discussion
The mechanism by which CS exposure induces lung inflammation is not fully understood. In the current study, we show that exposure of bronchial epithelial cells to CS components induces a stress response mediated by Cer accumulation that is generated by increased SPL de novo synthesis. We previously proved that Cer de novo synthesis is not only enhanced during lung inflammation but it also sustains inflammatory exacerbations (Caretti et al. 2014) . Cer accumulating from the increased de novo synthesis may stimulate the activity of (Petrache et al. 2005) , which were proved to be activated by CS (Filosto et al. 2011; Lea et al. 2016) , giving rise to a vicious circle that amplifies endogenous Cer production and lung damage. Indeed, we observed a significant but not complete reduction of Cer upon inhibition of its de novo synthesis, possibly due to other inflammatory bystander events. We here demonstrated that inhibition of this pathological mechanism by two inhibitors, Myr and XM462, acting on two different steps of de novo synthesis of Cer, can significantly reduce diverse outcomes of the inflammatory cascades, responsible for the induction of CS-induced chronic damage in the airways. We selected a few highly toxic components of CS to treat bronchoepithelial cells. We observed a marked reduction of inflammatory mediators and metalloproteases transcription and the stimulation of antioxidant mechanisms upon Cer downregulation, demonstrating that a derangement in SPL metabolism controls both at transcription and activation levels the initiation of inflammation and promotes its exacerbation. Myr inhibits the synthesis of the common precursor of all SPL molecules. A more specific inhibitor of Cer increase is XM462, which impairs the desaturation of the dihydroceramide into Cer. Whereas dihydroceramide was considered inactive for long time, recent data assess its opposite role to Cer, acting via stimulation of autophagy and ER stress release (Gagliostro et al. 2012; Zheng et al. 2006) . The observation that such two different inhibitors, Myr and XM462, are both able to prevent inflammation and oxidative damage, address to the conclusion that Cer is a major mediator of CS damage and that the increased rate of its synthesis is a pathological mechanism exacerbated by CS-induced stress. Finally, we suggest the pharmacological inhibition of Cer de novo synthesis as a therapeutic strategy to alleviate CS-induced lung injury by reducing airway inflammation, proteolytic response, and by activating antioxidant defensive mechanisms.
